227 related articles for article (PubMed ID: 32282698)
1. Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study.
Fu H; Hu P; Ma C; Peng F; He Z
Medicine (Baltimore); 2020 Apr; 99(15):e19472. PubMed ID: 32282698
[TBL] [Abstract][Full Text] [Related]
2. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
Liang ZY; Han YL; Zhang XL; Li Y; Yan CH; Kang J
EuroIntervention; 2013 Jul; 9(3):316-27. PubMed ID: 23872648
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke.
Rath CL; Jørgensen NR; Wienecke T
PLoS One; 2020; 15(12):e0236260. PubMed ID: 33370281
[TBL] [Abstract][Full Text] [Related]
4. Genotype Frequencies of CYP2C19, P2Y12 and GPIIIa Polymorphisms in Coronary Heart Disease Patients of Han Ethnicity, and Their Impact on Clopidogrel Responsiveness.
Ou W; He Y; Li A; Liu B; Jin L
Int Heart J; 2016 Sep; 57(5):586-92. PubMed ID: 27488401
[TBL] [Abstract][Full Text] [Related]
5. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.
Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X
Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921
[TBL] [Abstract][Full Text] [Related]
6. High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents.
Lv H; Yang Z; Wu H; Liu M; Mao X; Liu X; Ding H; Shi Z; Zhou Y; Liu Q; Zhang Y; Zhou Y; Chen K; Li Z; Dong Q; Ma J; Han Y
Transl Stroke Res; 2022 Jun; 13(3):391-398. PubMed ID: 34596891
[TBL] [Abstract][Full Text] [Related]
7. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
[TBL] [Abstract][Full Text] [Related]
8. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF
CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117
[TBL] [Abstract][Full Text] [Related]
9. Genotyping-guided approach versus the conventional approach in selection of oral P2Y12 receptor blockers in Chinese patients suffering from acute coronary syndrome.
Tam CC; Kwok J; Wong A; Yung A; Shea C; Kong SL; Tang WH; Siu D; Chan R; Lee S
J Int Med Res; 2017 Feb; 45(1):134-146. PubMed ID: 28222641
[TBL] [Abstract][Full Text] [Related]
10. A study of microRNA-223 in evaluating platelet reactivity in patients with acute ischemic stroke.
Wang DL; Li X; Wang RN; Sun Y; Xia XS; Tian WJ; Wang L
J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35793763
[TBL] [Abstract][Full Text] [Related]
11. Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors.
Tomek A; Matʼoška V; Frýdmanová A; Magerová H; Šrámek M; Paulasova-Schwabová J; Růžičková T; Janský P; Šarbochová I; Hadačová I; Kaplan V; Lacinová Z; Táborský L; Serebruany V
Am J Ther; 2018; 25(2):e202-e212. PubMed ID: 29509167
[TBL] [Abstract][Full Text] [Related]
12. CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome.
Liu J; Nie XY; Zhang Y; Lu Y; Shi LW; Wang WM
Chin Med J (Engl); 2015 Aug; 128(16):2183-8. PubMed ID: 26265611
[TBL] [Abstract][Full Text] [Related]
13. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
[TBL] [Abstract][Full Text] [Related]
14. The association between high on-treatment platelet reactivity and early recurrence of ischemic events after minor stroke or TIA.
Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Wang Y; Cao Y
Neurol Res; 2017 Aug; 39(8):719-726. PubMed ID: 28398139
[TBL] [Abstract][Full Text] [Related]
15. Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention.
Rideg O; Komócsi A; Magyarlaki T; Tokés-Füzesi M; Miseta A; Kovács GL; Aradi D
Pharmacogenomics; 2011 Sep; 12(9):1269-80. PubMed ID: 21806387
[TBL] [Abstract][Full Text] [Related]
16. Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity.
Nie XY; Li JL; Zhang Y; Xu Y; Yang XL; Fu Y; Liang GK; Lu Y; Liu J; Shi LW
J Zhejiang Univ Sci B; 2017 Jan.; 18(1):37-47. PubMed ID: 28070995
[TBL] [Abstract][Full Text] [Related]
17. CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han.
Wang JY; Zhang YJ; Li H; Hu XL; Li MP; Song PY; Ma QL; Peng LM; Chen XP
Gene; 2018 Dec; 678():226-232. PubMed ID: 30096456
[TBL] [Abstract][Full Text] [Related]
18. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
[TBL] [Abstract][Full Text] [Related]
19. Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.
Sun W; Li Y; Li J; Zhang Z; Zhu W; Liu W; Cai Q; Wang X; Cao L; Bai W; Fan X; Ma M; Guo R; Liu X; Xu G
Platelets; 2015; 26(6):558-62. PubMed ID: 25207801
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
